1. Protective effects of tauroursodeoxycholate against radiation-induced intestinal injury in a mouse model.
- Author
-
Lee J, Jeon BS, Kang S, Son Y, Lim YB, Bae MJ, Jo WS, Lee CG, Shin IS, Moon C, Lee HJ, and Kim JS
- Subjects
- Animals, Mice, Male, Intestines radiation effects, Intestines drug effects, Intestines pathology, Disease Models, Animal, Intestinal Mucosa drug effects, Intestinal Mucosa radiation effects, Intestinal Mucosa pathology, Intestinal Mucosa metabolism, Radiation Injuries, Experimental prevention & control, Radiation Injuries, Experimental pathology, Radiation Injuries, Experimental drug therapy, Radiation Injuries, Experimental metabolism, Matrix Metalloproteinase 13 metabolism, Cell Proliferation drug effects, Cell Proliferation radiation effects, Taurochenodeoxycholic Acid pharmacology, Mice, Inbred C57BL, Endoplasmic Reticulum Stress drug effects, Endoplasmic Reticulum Stress radiation effects, Apoptosis drug effects, Apoptosis radiation effects, Radiation-Protective Agents pharmacology
- Abstract
In patients with high-level radiation exposure, gastrointestinal injury is the main cause of death. Despite the severity of damage to the gastrointestinal tract, no specific therapeutic option is available. Tauroursodeoxycholic acid (TUDCA) is a conjugated form of ursodeoxycholic acid that suppresses endoplasmic reticulum (ER) stress and regulates various cell-signaling pathways. We investigated the effect of TUDCA premedication in alleviating intestinal damage and enhancing the survival of C57BL/6 mice administered a lethal dose (15Gy) of focal abdominal irradiation. TUDCA was administered to mice 1 h before radiation exposure, and reduced apoptosis of the jejunal crypts 12 h after irradiation. At later timepoint (3.5 days), irradiated mice manifested intestinal morphological changes that were detected via histological examination. TUDCA decreased the inflammatory cytokine levels and attenuated the decrease in serum citrulline levels after radiation exposure. Although radiation induced ER stress, TUDCA pretreatment decreased ER stress in the irradiated intestinal cells. The effect of TUDCA indicates the possibility of radiation therapy for cancer in tumor cells. TUDCA did not affect cell proliferation and apoptosis in the intestinal epithelium. TUDCA decreased the invasive ability of the CT26 metastatic colon cancer cell line. Reduced invasion after TUDCA treatment was associated with decreased matrix metalloproteinase (MMP)-7 and MMP-13 expression, which play important roles in invasion and metastasis. This study shows a potential role of TUDCA in protecting against radiation-induced intestinal damage and inhibiting tumor cell migration without any radiation and radiation therapy effect., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Joong Sun Kim reports financial support was provided by National Research Foundation of Korea. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF